Richard Saintvilus

After 20 successful years in the IT industry, Saintvilus decided his second act would be as a stock analyst -- bringing logic from an investor's point of view. Richard's work has been featured on CNBC, Yahoo! Finance, MSN Money, Forbes, Motley Fool and numerous other outlets.

 

Recent Articles By The Author

Buy Express Scripts at $73, Not Near $77

Buy Express Scripts at $73, Not Near $77

Express Scripts stock looks poised to drop.

Buy Kimberly-Clark on Near-Term Weakness

Buy Kimberly-Clark on Near-Term Weakness

Kimberly-Clark is expected to buy back between $700 million to $800 million of its shares in the next two quarters. It stock is a no-brainer.

Wait for Another 10% Drop In Gilead Before Buying

Wait for Another 10% Drop In Gilead Before Buying

The stock is poised to test support at around $78 per share, or 10% lower. At that point, Gilead stock is safe to buy. Anything in between is trap.

Sprint Is Soaring so Take Profits Now

Sprint Is Soaring so Take Profits Now

Wait for a pullback to resistance at around $5 per share, or about 15% lower, before buying back in.

Take Profits in PetMed, Then Wait for a Pullback

Take Profits in PetMed, Then Wait for a Pullback

At best, the stock should be priced at around $18, or 12% lower.